S. Margaret Paik to Aromatase Inhibitors
This is a "connection" page, showing publications S. Margaret Paik has written about Aromatase Inhibitors.
Connection Strength
0.144
-
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019 01; 20(1):88-99.
Score: 0.144